Status:
COMPLETED
Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
Lead Sponsor:
University of South Alabama
Collaborating Sponsors:
Elysium Health, Inc.
Conditions:
Menopause
Eligibility:
FEMALE
35+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether a short supplementation (7days) with BASIS™ increases the natural production of estradiol, measured in urinary waste. The overall objective is to dete...
Detailed Description
Protocol Outline Protocol Title: Effects of a seven-day BASIS™ supplementation on menopausal syndromes and measurements of the urinary vitamin B3 and estradiol levels in pre-, peri- and post-menopaus...
Eligibility Criteria
Inclusion
- 35 years of age or older
- pre, peri or post menopausal
Exclusion
- Less than 35 years of age
- Hormone replacement therapy
Key Trial Info
Start Date :
April 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04841499
Start Date
April 5 2021
End Date
July 15 2021
Last Update
November 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Alabama
Mobile, Alabama, United States, 36604